Pfizer Inc. on Tuesday announced a licensing agreement with the Wisconsin Alumni Research Foundation, or WARF, for the development of drug therapies using human embryonic stem cells.
The pharmaceutical giant said it would use embryonic stem cells, discovered by UW-Madison researcher James Thomson in 1998, to improve drug safety, screen new drugs and develop cell therapies.